Conditions

Sickle cell disease: the world's leading genetic disease

Painful crises, anemia, prevention of complications

Dr. Camille Roux

Hematologist

7 min read
Sickle cell disease: the world's leading genetic disease

Abnormal hemoglobin

Sickle cell disease is caused by a mutation in the β-globin gene producing hemoglobin S. Red blood cells take on a sickle shape, obstruct small blood vessels, and are prematurely destroyed. More than 300,000 children are born with the disease each year.

Manifestations

Painful vaso-occlusive crises (bone, abdominal), chronic hemolytic anemia, susceptibility to infections (functional asplenia), acute chest syndrome, stroke, kidney and retinal damage.

Treatments

  • Hydroxyurea: increases fetal hemoglobin, reduces crises
  • Transfusions and exchange programs
  • Voxelotor, crizanlizumab: new molecules
  • Bone marrow transplant: only widely available curative treatment
  • Gene therapy (Casgevy, Lyfgenia): approved in 2023-2024, major prospects

Prevention

Enhanced vaccinations, pediatric antibiotic prophylaxis, hydration, systematic neonatal screening.

#sickle cell disease#genetic#hemoglobin